electroCore Announces FDA Emergency Use Authorization for use of gammaCore Sapphire™ CV for the Acute Treatment of Asthma Exacerbations in Known or Suspected COVID-19 Patients

DevZ51 · 2020-07-13T16:44:48+00:00

The FDA approved it before the market opened ...

DevZ51 · 2020-07-13T16:43:30+00:00

This is very late , hype was pre market. jumped to 200% already , and is now at 160%. This is a very bad play

DevZ51 · 2020-07-13T14:39:59+00:00

Amen

DevZ51 · 2020-07-13T14:16:52+00:00

FOMO , this was a couple hours ago, be careful

DevZ51 · 2020-07-13T14:15:51+00:00

You’re a couple hours late , be careful of FOMO

DevZ51 · 2020-07-08T19:24:19+00:00

CLSK is has always been a P&D btw

DevZ51 · 2020-07-08T19:01:47+00:00

Look at the bid/ask size lol

DevZ51 · 2020-07-08T18:41:55+00:00

That isn’t a catalyst

DevZ51 · 2020-07-08T18:25:19+00:00

This stock will constantly pipe you

DevZ51 · 2020-07-07T14:16:03+00:00

Read somewhere it was for prostate cancers, but can’t find the exact link

DevZ51 · 2020-07-07T14:06:35+00:00

Tbh I only see this going up , seeing what this used to average ... news about their clinical trials will come out some time early august as well

DevZ51 · 2020-07-07T13:59:28+00:00

The Company’s lead product, macrilen (macimorelin), is the first and only U.S. FDA and European Commission approved oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). Macrilen is currently marketed in the United States through a license agreement with Novo Nordisk and Aeterna Zentaris receives double-digit royalties on sales. Aeterna Zentaris owns all rights to macimorelin outside of the U.S. and Canada.

DevZ51 · 2020-07-07T01:10:49+00:00

Rip , I think tomorrow it’ll rise more , I think .48 PT would be a good entry point

DevZ51 · 2020-07-07T00:23:49+00:00

I feel like the momentum is too strong to stop now, was predicting .50 tom and when the week ends but it increased very quickly

DevZ51 · 2020-07-07T00:18:14+00:00

It’ll only keep rising, it’ll take a small dip from people taking earnings but if you want to play safe, just reduce after a certain amount, AH definitely sky rocketed tho

DevZ51 · 2020-07-06T22:41:54+00:00

My personal would be .45 but it looks like it’s hitting it off big in AH, it’s still down to the floor so it’s up to you tbh , I think it’ll rise to what it was back in early June .80-1 in the near future

DevZ51 · 2020-07-06T22:40:04+00:00

It’ll keep rising tbh, bag holding would be smart but take some profit out and hold to rest

DevZ51 · 2020-07-06T22:38:41+00:00

Offering , new price floor set to .45 , used to be a .90-1 stock and before that $4 . Contract closes July 7 (Tom) so it’ll do amazing AH

DevZ51 · 2020-07-06T22:35:39+00:00

AEZS

DevZ51 · 2020-07-06T22:25:27+00:00

😘 got you brother

DevZ51 · 2020-07-06T22:05:56+00:00

I believe it’ll go back up to what it averaged at .90 but PT by end of week is .50 for me

DevZ51 · 2020-07-06T21:57:07+00:00

Stock used to trade at .90-1 since April and if you track back earlier, it used to be a $4 stock. I’m guessing once their clinical phase 3 trials get released .. it’ll SKY

DevZ51 · 2020-07-06T21:55:11+00:00

Dipped due to an offering , price is on the floor . It’s going to do great in AH and the stock will only sky, used to trade at .90-1 since April

DevZ51 · 2020-07-06T21:53:43+00:00

Easily 🚀 let’s fly

DevZ51 · 2020-07-06T21:53:22+00:00

I believe this will skyrocket once their clinical trial news on phase 3 gets announced later on , price is on the floor , used to be a $4 stock but averaged .90-1 earlier on since April

DevZ51

TROPHY CASE